arXiv:2506.03972cs.CV2025-06被引 1

提出MS-YOLO模型,精准高效检测血细胞,尤其擅长小目标和重叠细胞。

MS-YOLO: A Multi-Scale Model for Accurate and Efficient Blood Cell Detection

  • 采用多尺度扩张残差模块、动态特征融合与自适应下采样,提升多尺度识别能力。
  • 在CBC数据集上实现97.4%的mAP@50,对血小板等小目标检测精度显著提升。
  • 轻量化设计支持实时推理,适合临床场景部署,兼顾准确率与效率。

全血细胞检测在临床诊断中具有重要意义。传统人工显微镜方法存在耗时长、误诊率高等问题,现有自动化检测手段仍受限于高部署成本与精度不足。尽管深度学习为该领域带来新范式,但重叠细胞与多尺度目标的检测难题仍制约实际应用。本研究提出基于YOLOv11框架的多尺度YOLO(MS-YOLO)模型,引入三项核心改进:多尺度扩张残差模块(MS-DRM)替代原C3K2模块以增强多尺度判别力;动态跨路径特征增强模块(DCFEM)实现主干网络与颈部特征的分层融合,提升表征能力;轻量自适应权重下采样模块(LADS)通过自适应空间加权优化下采样过程,降低计算复杂度。在CBC基准数据集上的实验表明,MS-YOLO可精准检测重叠细胞与多尺度目标,尤其在血小板等小目标上表现突出,mAP@50达97.4%,优于现有模型。在补充数据集WBCDD上的验证进一步证明其强泛化能力。同时,凭借轻量架构与实时推理性能,该模型满足临床部署需求,为标准化血液病理评估提供可靠技术支持。

原文摘要 · Abstract (English)

Complete blood cell detection holds significant value in clinical diagnostics. Conventional manual microscopy methods suffer from time inefficiency and diagnostic inaccuracies. Existing automated detection approaches remain constrained by high deployment costs and suboptimal accuracy. While deep learning has introduced powerful paradigms to this field, persistent challenges in detecting overlapping cells and multi-scale objects hinder practical deployment. This study proposes the multi-scale YOLO (MS-YOLO), a blood cell detection model based on the YOLOv11 framework, incorporating three key architectural innovations to enhance detection performance. Specifically, the multi-scale dilated residual module (MS-DRM) replaces the original C3K2 modules to improve multi-scale discriminability; the dynamic cross-path feature enhancement module (DCFEM) enables the fusion of hierarchical features from the backbone with aggregated features from the neck to enhance feature representations; and the light adaptive-weight downsampling module (LADS) improves feature downsampling through adaptive spatial weighting while reducing computational complexity. Experimental results on the CBC benchmark demonstrate that MS-YOLO achieves precise detection of overlapping cells and multi-scale objects, particularly small targets such as platelets, achieving an mAP@50 of 97.4% that outperforms existing models. Further validation on the supplementary WBCDD dataset confirms its robust generalization capability. Additionally, with a lightweight architecture and real-time inference efficiency, MS-YOLO meets clinical deployment requirements, providing reliable technical support for standardized blood pathology assessment.

目标检测医学图像YOLO血细胞分析

Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。